| Long name: |
TIAF1 Primary Polyclonal Antibody |
| Also known as: |
TIAF1 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
TIAF1 |
| Specificity: |
This is a highly specific antibody against TIAF1 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human TIAF1 |
| Gene ID number: |
9220 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
MAJN or MYSPDZ, MysPDZ-Alpha consists of a KE-rich region, MysPDZ-Alpha is present in most tissues and is known to co-localize with the ER-Golgi complex and with membrane ruffles and filopodia, MysPDZ-Beta is expressed specifically in hematopoietic tissues and cell lines and shows dispersed localization in the cytoplasm, Two isoforms of mouse TIAF-1 exist and are designated MysPDZ-Alpha and MysPDZ-Beta, also known as MYO18A, an N-terminal PDZ domain and a prevalent myosin homologous head region, is a TGF Beta 1-induced anti-apoptotic factor that localizes to the nucleus and functions to inhibit the cytotoxic effects of TNF? TRADD and FADD, while the MysPDZ-Beta isoform lacks the KE-rich region and PDZ domain, TIAF-1 (TGF Beta 1-induced antiapoptotic factor 1) |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
TGFB1 induced anti apoptotic factor 1, TGFB1 induced anti apoptotic factor 1 12 kDa TGF beta1 induced antiapoptotic factor, TIAF1_HUMAN, MAJN |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
TIAF1 |
| Short name: |
TIAF1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
TGFB1-induced antibody to-apoptotic factor 1 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
MAJN and SPR210, TIAF1 and IDBG-281602 and ENSG00000221995 and 9220, molecular_function, nuclei, this GO :0003674 and molecular function and molecular function this GO :0005634 and nucleus and cellular component this GO :0006915 and apoptotic process and biological process this GO :0007249 and I-kappaB kinase/NF-kappaB signaling and biological process this GO :0043066 and negative regulation of apoptotic process and biological process, this GO :0003674 : molecular_function, this GO :0003674 : molecular_function, TGFB1-induced anti-apoptotic factor 1 |
| Identity: |
11803 |
| Gene: |
TIAF1 |
More about : TIAF1 |
| Long gene name: |
TGFB1-induced anti-apoptotic factor 1 |
| Locus: |
17q11, 2 |
| Discovery year: |
1999-05-14 |
| GenBank acession: |
AF105277 |
| Entrez gene record: |
9220 |
| Pubmed identfication: |
9918798 |
| RefSeq identity: |
NM_004740 |
| Havana BLAST/BLAT: |
OTTHUMG00000163268 |